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Introduction
Cogan’s syndrome is a rare disorder of unknown origin
characterized by inflammatory eye disease and vestibu-
loauditory symptoms. Usually syndrome affects young
adults but cases in children have been reported. Typically,
patients suffer from interstitial keratitis and sudden onset
of tinnitus and hearing loss.
Objectives
To review clinical characteristics of patients who develop
Cogan’s syndrome and review treatment possibilities.
Methods
We describe 17 years old boy, previously healthy, who
developed headaches, fever, lower leg weakness and pain,
hypotension and conjuctivitis. Patient also developed mild
stomatitis and during fever a couple of times patient devel-
oped maculopapular rash on his arms. After a month
patient started to complain of vertigo, tinnitus and sudden
hearing loss and after exclusion of acute and chronic
infections and haematooncological disease treatment with
steroids was started in addition with azathioprine. His tin-
nitus resolved after first steroid-pulse but hearing loss fully
restored only in one ear.
Results
Cogan’s syndrome is a rare autoimmune vasculitis charac-
terized by ocular and vestibuloauditory dysfunction,
mostly described in young Caucasian patients of either
sex. Etiology is unknown but infection and autoimmunity
plays role in the development of Cogan’s syndrome. In
addition to ocular and vestibuloauditory involvement,
numerous systemic manifestations have been reported,
including aortitits, necrotizing vasculitis, constitutional
features, gastrointestinal and neurological manifestations.
There is no specific laboratory findings of Cogan’s
syndrome. Disease course is variable. Treatment can
include glucocorticoids and in case of failure, other immu-
nosuppressive drugs can be used.
Conclusion
Despite its rarity, Cogan’s syndrome is an important
condition to recognize because early treatment may
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